DK2371854T3 - Induktion af tumorimmunitet med varianter af folatbindende protein - Google Patents

Induktion af tumorimmunitet med varianter af folatbindende protein

Info

Publication number
DK2371854T3
DK2371854T3 DK11004714.9T DK11004714T DK2371854T3 DK 2371854 T3 DK2371854 T3 DK 2371854T3 DK 11004714 T DK11004714 T DK 11004714T DK 2371854 T3 DK2371854 T3 DK 2371854T3
Authority
DK
Denmark
Prior art keywords
tumorimmunity
volate
induction
variety
binding protein
Prior art date
Application number
DK11004714.9T
Other languages
English (en)
Inventor
Constantin G Ioannides
George E Peoples
Original Assignee
Univ Texas
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Jackson H M Found Military Med filed Critical Univ Texas
Application granted granted Critical
Publication of DK2371854T3 publication Critical patent/DK2371854T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK11004714.9T 2001-03-09 2002-03-08 Induktion af tumorimmunitet med varianter af folatbindende protein DK2371854T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27467601P 2001-03-09 2001-03-09
EP02750589A EP1472337A4 (en) 2001-03-09 2002-03-08 INDUCTION OF TUMOR IMMUNITY BY VARIANTS OF FOLATE FIXATION PROTEIN

Publications (1)

Publication Number Publication Date
DK2371854T3 true DK2371854T3 (da) 2014-08-11

Family

ID=23049174

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11004714.9T DK2371854T3 (da) 2001-03-09 2002-03-08 Induktion af tumorimmunitet med varianter af folatbindende protein

Country Status (9)

Country Link
US (5) US7547759B2 (da)
EP (2) EP1472337A4 (da)
JP (3) JP4401075B2 (da)
CA (1) CA2440610C (da)
DK (1) DK2371854T3 (da)
ES (1) ES2502366T3 (da)
PT (1) PT2371854E (da)
SI (1) SI2371854T1 (da)
WO (1) WO2002072766A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2371854T3 (da) * 2001-03-09 2014-08-11 Univ Texas Induktion af tumorimmunitet med varianter af folatbindende protein
JP2008533114A (ja) * 2005-03-18 2008-08-21 ユーシーエル ビジネス パブリック リミテッド カンパニー メカノ成長因子ペプチドおよびその使用
US8133691B2 (en) 2005-07-06 2012-03-13 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Stable quantitation and detection of immune response levels with non-zero background peptides
CN101253199B (zh) 2005-08-30 2019-06-14 迈阿密大学 免疫调节肿瘤坏死因子受体25(tnfr25)的激动剂、拮抗剂和免疫毒素
US8486412B2 (en) 2006-06-01 2013-07-16 Mayo Foundation For Medical Education And Research Immunity to folate receptors
WO2016196506A1 (en) * 2015-05-29 2016-12-08 Galena Biopharma, Inc. PEPTIDE VACCINE THERAPY FOR TREATMENT OF FRα-EXPRESSING TUMORS
WO2017210255A1 (en) 2016-05-31 2017-12-07 Galena Biopharma, Inc. Vaccine therapy for treatment of endometrial and ovarian cancer
EP3290395A1 (en) * 2016-09-02 2018-03-07 Paques I.P. B.V. Anaerobic purification device with variable water column
WO2018152451A1 (en) * 2017-02-17 2018-08-23 Purdue Research Foundation Targeted ligand-payload based drug delivery for cell therapy

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826364A (en) 1972-05-22 1974-07-30 Univ Leland Stanford Junior Particle sorting method and apparatus
US4284412A (en) 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses
US4596792A (en) 1981-09-04 1986-06-24 The Regents Of The University Of California Safe vaccine for hepatitis containing polymerized serum albumin
US4498766A (en) 1982-03-25 1985-02-12 Becton, Dickinson And Company Light beam focal spot elongation in flow cytometry devices
JPS5938877A (ja) 1982-08-30 1984-03-02 Musashi Eng Kk 紙葉判別方法
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US5384253A (en) 1990-12-28 1995-01-24 Dekalb Genetics Corporation Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
US6419931B1 (en) * 1991-08-26 2002-07-16 Epimmune Inc. Compositions and methods for eliciting CTL immunity
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US6514942B1 (en) * 1995-03-14 2003-02-04 The Board Of Regents, The University Of Texas System Methods and compositions for stimulating T-lymphocytes
US5830755A (en) * 1995-03-27 1998-11-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services T-cell receptors and their use in therapeutic and diagnostic methods
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
WO1997025068A2 (en) * 1996-01-05 1997-07-17 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Mesothelin antigen and methods and kits for targeting it
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
DE60226853D1 (de) * 2001-02-20 2008-07-10 Ortho Mcneil Pharm Inc Zelltherapieverfahren für die behandlung von tumoren
DK2371854T3 (da) * 2001-03-09 2014-08-11 Univ Texas Induktion af tumorimmunitet med varianter af folatbindende protein
WO2016196506A1 (en) * 2015-05-29 2016-12-08 Galena Biopharma, Inc. PEPTIDE VACCINE THERAPY FOR TREATMENT OF FRα-EXPRESSING TUMORS

Also Published As

Publication number Publication date
EP2371854A3 (en) 2011-12-21
US8815256B2 (en) 2014-08-26
US7547759B2 (en) 2009-06-16
US20180194806A1 (en) 2018-07-12
US8258261B2 (en) 2012-09-04
WO2002072766A8 (en) 2004-09-02
JP2004532825A (ja) 2004-10-28
PT2371854E (pt) 2014-08-25
EP2371854B1 (en) 2014-05-07
JP2009114190A (ja) 2009-05-28
US20130039935A1 (en) 2013-02-14
CA2440610C (en) 2011-07-12
JP2012097111A (ja) 2012-05-24
US20030185840A1 (en) 2003-10-02
ES2502366T3 (es) 2014-10-03
US20150175658A1 (en) 2015-06-25
JP4401075B2 (ja) 2010-01-20
EP1472337A1 (en) 2004-11-03
US9562070B2 (en) 2017-02-07
EP1472337A4 (en) 2008-02-27
SI2371854T1 (sl) 2014-09-30
CA2440610A1 (en) 2002-09-19
US20090227510A1 (en) 2009-09-10
EP2371854A2 (en) 2011-10-05
JP5017238B2 (ja) 2012-09-05
WO2002072766A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
DE10224526B8 (de) Elektromagnetische Induktionsverbindung
DE60332821D1 (de) Induktionsheizeinrichtung
DE60331202D1 (de) Induktionsheizvorrichtung
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
DK1438306T3 (da) Derivater af UK-2A
DK1353941T3 (da) Modificerede zinkfingerbindingsproteiner
DE60210160D1 (de) Snowboardbindung
DE50206101D1 (de) Induktives bauteil
DK1410012T3 (da) Bestemmelse af graviditetstilstand
DE60332361D1 (de) Induktionsheizspule
NO20034921D0 (no) Skibinding
DE60238924D1 (de) Abwälzfräser
EE200300569A (et) CD44v6-spetsiifilised antikehad
DE10160799B4 (de) Zusatzheizung
DK2371854T3 (da) Induktion af tumorimmunitet med varianter af folatbindende protein
PT1345624E (pt) Inducao de tolerancia
DE60229186D1 (de) Heizelement
DE60201193D1 (de) Induktives Bauteil
DE602004029269D1 (de) Induktionserwärmung
ATE523892T1 (de) Klemmhilfe
DE50209602D1 (de) Magnetisches bauelement
DE50213467D1 (de) Skibindung
DE60223840D1 (de) Magnetische tonerzusammensetzung
DE60207467D1 (de) Snowboardbindung
DE50202940D1 (de) Ausrichtelement